Similar Search Results

Expected Profits and the Scientific Novelty of Innovation

Dranove, David; Garthwaite, Craig; Hermosilla, Manuel - 2022

Innovation policy involves trading off monopoly output and pricing in the short run in exchange for incentives for …

Persistent link: https://www.econbiz.de/10013309194

The U.S. Patent System in Transition : Policy Innovation and the Innovation Process

Jaffe, Adam B. - 2021

relating to patenting, robust conclusions regarding the empirical consequences for technological innovation of changes in …

Persistent link: https://www.econbiz.de/10013226916

The Future of Drug Development : The Economics of Pharmacogenomics

Vernon, John A.; Hughen, W. Keener; Vernon, John A. - 2021

This paper models how the evolving field of pharmacogenomics (PG), which is the science of using genomic markers to predict drug response, may impact drug development times, attrition rates, costs, and the future returns to research and development (R&D). While there still remains an abundance...

Persistent link: https://www.econbiz.de/10013311658

The Role of Assets in Place : Loss of Market Exclusivity and Investment

Higgins, Matthew John; Kronlund, Mathias; Park, Ji Min; … - 2022

We utilize a novel identification strategy to analyze the impact of assets in place on firms' decisions for future projects. We exploit the context in the pharmaceutical industry, where the loss of market exclusivity for a branded drug can be used to separate the impact of cash flows generated...

Persistent link: https://www.econbiz.de/10013406834

Private and Social Returns to R&D : Drug Development and Demographics

Benmelech, Efraim; Eberly, Janice; Krieger, Joshua; … - 2022

Investment in intangible capital—in particular, research and development—increased dramatically since the 1990s. However, productivity growth remains sluggish in recent years. One potential reason is that a significant share of the increase in intangible investment is geared toward consumer...

Persistent link: https://www.econbiz.de/10014264816

The Cost of Us Pharmaceutical Price Reductions : A Financial Simulation Model of R&D Decisions

Abbott, Thomas A.; Vernon, John A. - 2021

Previous empirical studies that have examined the links between pharmaceutical price controls, profits, cash flows, and investment in research and development (R&D) have been largely based on retrospective statistical analyses of firm- and/or industry-level data. These studies, which have...

Persistent link: https://www.econbiz.de/10013227913

Innovation and Diffusion of Clean/Green Technology : Can Patent Commons Help?

Hall, Bronwyn H. - 2012

investigate the motives of the contributing firms as well as the potential for such commons to encourage innovation and diffusion … knowledge management that combine open innovation and patenting …

Persistent link: https://www.econbiz.de/10013114981

Patent Rights, Product Market Reforms, and Innovation

Aghion, Philippe - 2014

paper, we address this question by investigating how innovation responses to a substantial policy initiative increasing … product market competition interact with the strength of patent rights. We provide empirical evidence of innovation responding … with step-by-step innovation models predicting that product market competition enhances innovation and, more importantly …

Persistent link: https://www.econbiz.de/10013064451

Patent Laws and Innovation : Evidence from Economic History

Moser, Petra - 2014

What is the optimal system of intellectual property rights to encourage innovation? Empirical evidence from economic … existence of strong patent laws encourage innovation? And 2) May patent laws influence the direction - as opposed to the rate … innovations in developing countries, discourage innovation in the developing countries? This essay summarizes results of existing …

Persistent link: https://www.econbiz.de/10013064853

Do Patent Pools Encourage Innovation? Evidence from 20 U.S. Industries Under the New Deal

Lampe, Ryan - 2014

tolerance under the New Deal to investigate the effects of pools on innovation within 20 industries. Difference … discourage innovation by weakening competition to improve substitutes …

Persistent link: https://www.econbiz.de/10013065642